| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,952 |
807 |
$106K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,484 |
525 |
$19K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
322 |
230 |
$13K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
133 |
133 |
$11K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
208 |
171 |
$8K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
45 |
45 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
146 |
145 |
$2K |
| 87481 |
|
301 |
235 |
$2K |
| 87631 |
|
47 |
47 |
$870.79 |
| 87500 |
|
184 |
180 |
$861.50 |
| 87641 |
|
182 |
176 |
$763.02 |
| 87653 |
|
181 |
176 |
$754.06 |
| 87581 |
|
39 |
39 |
$491.89 |
| 87498 |
|
39 |
39 |
$491.89 |
| 87486 |
|
39 |
39 |
$491.89 |
| 87541 |
|
39 |
39 |
$491.89 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
17 |
17 |
$229.92 |
| 87634 |
|
17 |
17 |
$187.17 |